|Clinical features of 11 cases of inflammatory myofibroblastic tumor with RANBP2-ALK gene fusion|
|Case||Author||Age||Sex||Anatomic site(s)||Size (cm)||Treatment||Follow-up|
|1||Ma  (2003)||7 y||Male||Unspecified abdominal mass||NA||SE + CT||Recurred 5 weeks later after first resection. A re-excision was performed. Five months later, the tumor recurred again and was re-excised.|
|2||7 m||Male||Mesentery and omentum||11||SE||Recurred 8 months later after first resection. A re-excision was performed.|
|3||Patel  (2007)||2 y||Male||Retroperitoneal abdominal mass||10||SE||No evidence of recurrence with 3 years of follow-up.|
|4||Chen  (2008)||34 y||Male||Liver||8||SE||Recurred 5 months later after resection. Died of the disease approximately 2 weeks after discovery of the recurrence.|
|5||Butrynski  (2010)||44 y||Male||Omentum||NA||SE + CT + ALKi||Hepatic, peripancreatic, and perirectal masses recurred 1 year later after resection. Subsequent exploratory laparotomy with maximal debulking was performed.|
|6||Marino-Enriquez  (2011)||41 y||Male||Omentum||26||SE + CT + ALKi||Multifocal local recurrence and liver metastases. Alive with no evidence of disease for 40 months.|
|7||6 y||Male||Omentum and Mesentery||14||SE||NA|
|8||39 y||Male||Mesentery of the small bowel||14||SE||NA|
|9||Kozu  (2013)||57 y||Male||Pluera or chest wall||NA||ALKi||NA|
|10||Present cases (2013)||19 y||Female||Mesentery of the small bowel||19||SE||Recurred 9 weeks later after resection. Died of the disease 3 weeks later after discovery of the recurrence.|
|11||39 y||Male||Mesentery of the colon||15||SE + CT||Recurred 4 months later after resection. Alive with disease for 12 months.|
SE surgical excision, CT chemotherapy, ALKi ALK inhibitor, NA data not available.
Li et al.
Li et al. Diagnostic Pathology 2013 8:147 doi:10.1186/1746-1596-8-147